about us:


Olon S.p.A. is a worldwide leader in the development and production of APIs (Active Pharmaceutical Ingredients). The ideal partner for custom synthesis and contract manufacturing projects.

news & events:


MADRID, 13 - 15 October 2015.

Visit us at BOOTH # 12C34

products search:


focus on:


POMALIDOMIDE

Olon S.p.A. is going to finalise its development project of Pomalidomide. The product is a cytostatic compound that will reinforce the current portfolio already including bicalutamide and thalidomide.

OSPEMIFENE

Olon S.p.A. is going to finalise its development project of Ospemifene. The product will complete our portfolio already including raloxifene, tamoxifen and toremifene.